Interleukin-17A (IL-17A)
Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome
9
Heterogeneous expression pattern of interleukin 17A (IL 17A), IL 17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti IL 17 therapy?
10
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
12
Interleukin-17A as a Biomarker for Bovine Tuberculosis
13
Mechanistic rationales for targeting interleukin 17A in spondyloarthritis
9
Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways
8
Elevated serum levels of interleukin-17A in children with autism
6
The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients
9
Intraocular Levels of Interleukin 17A (IL-17A) and IL-10 as Respective Determinant Markers of Toxoplasmosis and Viral Uveitis
7
Polymorphisms in interleukin 17A gene and coal workers’ pneumoconiosis risk in a Chinese population
8
Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials
7
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
15
Human limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto’s thyroiditis
14
Inherent low Erk and p38 activity reduce Fas Ligand expression and degranulation in T helper 17 cells leading to activation induced cell death resistance
21
Aberrant expression of interleukin 23 regulated miRNAs in T cells from patients with ankylosing spondylitis
10
<p>Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data</p>
11
Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
14
Long term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5 year results from the phase III MEASURE 1 extension study
8
Original Article Efficiency of IL-17a on neutrophil apoptosis and regulatory mechanisms in septic rats
8
Immunohistochemical characterization of feline lymphoplasmacytic anterior uveitis
12